Can MDMA cure PTSD? A new review finds the evidence is not yet strong enough to support cure claims and highlights unresolved safety, bias, and trial-design concerns

MDMA-assisted therapy for post-traumatic stress disorder shows promising results, but current evidence does not justify claims that MDMA can cure PTSD. A recent review points to meaningful symptom reductions in some clinical trials while stressing that remission and long-term recovery are not the same as a definitive cure. Key concerns include small samples, difficulties with blinding because MDMA's effects are obvious, expectancy bias, selective reporting, and limited follow-up. Safety questions also remain important, especially for people with cardiovascular risk, psychiatric comorbidity, or vulnerability to adverse psychological reactions. The review places the debate in a broader clinical context where enthusiasm, commercial pressure, and urgent patient need can outpace evidence standards. More rigorous trials with better controls, transparent reporting, and longer-term outcome data are needed before strong therapeutic or curative claims can be supported.